Oxaliplatin (Sun Pharma Global FZE)
Welcome to the PulseAid listing for the Oxaliplatin drug offered from Sun Pharma Global FZE. This Platinum-based Drug [EPC],Platinum-containing Compounds [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Sun Pharma Global FZE |
NON-PROPRIETARY NAME: | Oxaliplatin |
SUBSTANCE NAME: | OXALIPLATIN |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Platinum-based Drug [EPC],Platinum-containing Compounds [Chemical/Ingredient] |
ROUTE: | INTRAVENOUS |
DOSAGE FORM: | INJECTION, SOLUTION, CONCENTRATE |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2014-04-09 |
END MARKETING DATE: | 0000-00-00 |
Oxaliplatin HUMAN PRESCRIPTION DRUG Details:
Item Description | Oxaliplatin from Sun Pharma Global FZE |
LABELER NAME: | Sun Pharma Global FZE |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 50(mg/10mL) |
START MARKETING DATE: | 2014-04-09 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 47335-046_cf3dde66-d34e-4950-bea3-673266d21bc8 |
PRODUCT NDC: | 47335-046 |
APPLICATION NUMBER: | ANDA202922 |
Other OXALIPLATIN Pharmaceutical Manufacturers / Labelers: